Loading...

Powered by

DISCOVER MORE ABOUT OUR CONFERENCE

CHAIRMAN'S MESSAGE

On behalf of Sabah Al-Ahmad cardiac center it’s my pleasure to contribute in organizing such an important meeting that will highlight the most critical cause of mortality worldwide. As we all know deaths due to cardiometabolic diseases (endocrine, nutritional, and metabolic (ENM) diseases ( Diabetes, obesity and dyslipidemia ) hypertensive heart disease, ischemic heart disease and other vascular diseases such as stroke; All together are responsible for more than 4 million deaths in USA. Nevertheless, obesity has dramatically increased over the last decades and increase in BMI has been associated with increase mortality. In this one day focused summit our aim is to discuss all updates related to cardio metabolic diseases so the attendees can translate that into the clinical practice aiming to reduce the burden of those diseases locally.

I wish you all a fruitful meeting and regards to all the contributors and organizers of the event.

DR. RAJA DASHTI

Chairman - Cardiometabolic Networking Summit & Awareness Campaign 2024

know more

Speakers

Dr. Abdulnabi AlAttar
Dr. Ahmad AlSarraf
Dr. Ahmad AlShatti
Dr. Ali AlSahow
Dr. Ali Alsulaimi
Dr. Amna Al Shaghouli
Dr. Anas AlYousef
Dr. Hani Sabbour
Dr. Kausik K. Ray
Dr. Mohammad Jamal
Dr. Mohammed Al Dubayee
Dr. Muhammad Al-Shammari
Dr. Nawal AlOtaibi
Dr. Thamer AlEssa

Scientific Program

8:00 AM - 8:30 AM
-
Opening Ceremony
Session 1
Chairperson: Dr. Moosa Akbar, Dr. Yusuf Buabbas
8:30 AM - 8:45 AM
Dr. Ahmad AlSarraf
Shedding the light on the CVD in Kuwait
8:45 AM - 9:05 AM
Dr. Ahmad AlShatti
Lipid guidelines: Personalized care to prevent cardiovascular disease
9:05 AM - 9:25 AM
Dr. Hani Sabbour
Novel imaging methods for myocardial microvascular perfusion, structure and metabolism
9:25 AM - 9:45 AM
Dr. Kausik K. Ray
Management algorithm of FH
9:45 AM - 10:00 AM
Break
Session 2
Chairperson: Dr. Raja Dashti, Dr. Jamal Bulnaser
10:00 AM - 10:20 AM
Dr. Abdulnabi AlAttar
Prediabetes: Prevalence, diagnosis and management
10:20 AM - 10:40 AM
Dr. Thamer AlEssa
Stratified treatment of type-2 diabetes: Precision medicine for diabetes treatment
10:40 AM - 11:00 AM
Dr. Nawal AlOtaibi
The Golden age in obesity pharmacotherapy
11:00 AM - 11:20 AM
Lilly
Dr. Mohammad Jamal
Introducing Mounjaro; A new paradigm in Obesity Management
11:20 AM - 11:40 AM
-
Audience Competition
11:40 AM - 12:40 PM
Pray and Lunch Break
Session 3
Chairperson: Dr. Khalid AlMulla, Dr. Nadia Al-Ali
12:40 PM - 1:00 PM
Dr. Thamer AlEssa
NASH: Recent developments
1:00 PM - 1:20 PM
Dr. Anas AlYousef
International practice of dyslipidemia management in patients with chronic kidney disease: is it time to review guideline recommendations?
1:20 PM - 1:40 PM
Dr. Kausik K. Ray
Should we still target triglycerides to decrease cardiovascular risk?
1:40 PM - 2:00 PM
Novo Nordisk
Dr. Anas AlYousef
GLP-1 RAs and Cardiometabolic Health
2:00 PM - 2:10 PM
Break
Session 4
Chairperson: Dr. Awsan AlMohaini, Dr. Ahmad AlSarraf
2:10 PM - 2:30 PM
Sanofi
Dr. Ahmad AlShatti
State of Art Treatment in Dyslipidemia Patients
2:30 PM - 2:50 PM
Lilly
Dr. Amna Al Shaghouli
The Role of Tirzepatide in the management of Type 2 Diabetes
2:50 PM - 3:10 PM
Viatris
Dr. Muhammad Al-Shammari
Optimizing Dyslipidemia Management for High-Risk Patients
3:10 PM - 3:30 PM
Amgen
Dr. Ali Alsulaimi
The Role of Evolocumab in Dyslipidemia Management of Established MI Patients
3:30 PM - 3:40 PM
Break
3:40 PM - 4:00 PM
AstraZeneca
Dr. Ali AlSahow
aHUS: Raising Awareness and Changing Lives
4:00 PM - 4:20 PM
Dr. Mohammed Al Dubayee
The changing Face of HoFH in Pediatrics
4:20 PM - 4:40 PM
Novartis
Dr. Hani Sabbour
Focused Insights on Novel LDL-C Lowering Strategy: Inclisir an from Clinical Data into Practice
4:40 PM
Closing Ceremony & Audience Competition

Sponsors

Diamond Sponsor
Platinum Sponsors
Gold Sponsors
Silver Sponsors

Sponsors ads

Registration

Registration for this event is now closed!!